SUPPRESSION OF ADJUVANT-INDUCED ARTHRITIS IN RATS WITH 2-BUTOXYCARBONYLMETHYLENE-4-OXOTHIAZOLIDINE.
D000818:Animals; D000893:Anti-Inflammatory Agents; D001168:Arthritis; D001169:Arthritis, Experimental; D001665:Binding Sites; D002351:Carrageenan; D005534:Foot Diseases; D005557:Formaldehyde; D005620:Freund's Adjuvant; D007616:Kaolin; D007958:Leukocyte Count; D010600:Pharmacology; D010653:Phenylbutazone; D051381:Rats; D012106:Research; D013844:Thiazoles; D014116:Toxicology; D014374:Tuberculin Test
C482262:4-oxothiazolidine; D000893:Anti-Inflammatory Agents; D013844:Thiazoles; D005557:Formaldehyde; D007616:Kaolin; D002351:Carrageenan; D005620:Freund's Adjuvant; D010653:Phenylbutazone
ANTI-INFLAMMATORY AGENTS; ARTHRITIS; BINDING SITES; CARRAGEENAN; EXPERIMENTAL LAB STUDY; FOOT DISEASES; FORMALDEHYDE; FREUND'S ADJUVANT; KAOLIN; LEUKOCYTE COUNT; PHARMACOLOGY; PHENYLBUTAZONE; RATS; THIAZOLES; TOXICOLOGIC REPORT; TUBERCULIN TEST